Skip to main content
Log in

Percutaneous Vertebroplasty in Multiple Myeloma: Prospective Long-Term Follow-Up in 106 Consecutive Patients

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

Percutaneous vertebroplasty (PV) is a minimally invasive procedure involving the injection of bone cement within a collapsed vertebral body. Although this procedure was demonstrated to be effective in osteoporosis and metastases, few studies have been reported in cases of multiple myeloma (MM). We prospectively evaluated the safety and efficacy of PV in the treatment of vertebral compression fractures (VCFs) resulting from MM.

Materials and Methods

PV was performed in 106 consecutive MM patients who had back pain due to VCFs, the treatment of which had failed conservative therapies. Follow-up (28.2 ± 12.1 months) was evaluated at 7 and 15 days as well as at 1, 3, 6, 12, 18, and every 6 months after PV. Visual analog scale (VAS) pain score, opioid use, external brace support, and Oswestry Disability Index (ODI) score were recorded.

Results

The median pretreatment VAS score of 9 (range 4–10) significantly (P < 0.001) decreased to 1 (range 0–9) after PV. Median pre-ODI values of 82% (range 36–89%) significantly improved to 7% (range 0–82%) (P < 0.001). Differences in pretreatment and posttreatment use of analgesic drug were statistically significant (P < 0.001). The majority of patients (70 of 81; 86%) did not use an external brace after PV (P < 0.001).

Conclusion

PV is a safe, effective, and long-lasting procedure for the treatment of vertebral compression pain resulting from MM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Raab MS, Breitkreutz I, Anderson KC (2007) Targeted treatments to improve stem cell outcome: old and new drugs. Bone Marrow Transplant 40(12):1129–1137

    Article  PubMed  CAS  Google Scholar 

  2. Bjorkstrand B, Gahrton G (2007) High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future. Semin Hematol 44(4):227–233

    Article  PubMed  Google Scholar 

  3. von Lilienfeld-Toal M, Hahn-Ast C, Furkert K et al (2008) A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma. Eur J Haematol 81(4):247–252

    Article  Google Scholar 

  4. Curran MP, McKeage K (2009) Bortezomib: a review of its use in patients with multiple myeloma. Drugs 69(7):859–888

    Article  PubMed  CAS  Google Scholar 

  5. Musto P, Petrucci MT, Bringhen S et al (2008) A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma. Cancer 113(7):1588–1595

    Article  PubMed  Google Scholar 

  6. Callander NS, Roodman GD (2001) Myeloma bone disease. Semin Hematol 38(3):276–285

    Article  PubMed  CAS  Google Scholar 

  7. Rosen LS, Gordon D, Tchekmedyian NS et al (2004) Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial. Cancer 100(12):2613–2621

    Article  PubMed  CAS  Google Scholar 

  8. Saad F, Gleason DM, Murray R et al (2004) Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96(11):879–882

    Article  PubMed  CAS  Google Scholar 

  9. Lipton A, Theriault RL, Hortobagyi GN et al (2000) Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 88(5):1082–1090

    Article  PubMed  CAS  Google Scholar 

  10. de Wit R, van Dam F, Loonstra S et al (2001) The Amsterdam pain management index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain. Pain 91(3):339–349

    Article  PubMed  Google Scholar 

  11. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S (2001) Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93(3):247–257

    Article  PubMed  CAS  Google Scholar 

  12. Galibert P, Deramond H, Rosat P, Le Gars D (1987) Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty. Neurochirurgie 33(2):166–168

    PubMed  CAS  Google Scholar 

  13. Watts NB, Harris ST, Genant HK (2001) Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty. Osteoporos Int 12(6):429–437

    Article  PubMed  CAS  Google Scholar 

  14. Anselmetti GC, Corrao G, Monica PD et al (2007) Pain relief following percutaneous vertebroplasty: results of a series of 283 consecutive patients treated in a single institution. Cardiovasc Intervent Radiol 30(3):441–447

    Article  PubMed  Google Scholar 

  15. Barragan-Campos HM, Vallee JN, Lo D et al (2006) Percutaneous vertebroplasty for spinal metastases: complications. Radiology 238(1):354–362

    Article  PubMed  Google Scholar 

  16. Masala S, Anselmetti GC, Marcia S, Massari F, Manca A, Simonetti G (2008) Percutaneous vertebroplasty in multiple myeloma vertebral involvement. J Spinal Disord Techn 21(5):344–348

    Article  Google Scholar 

  17. Dudeney S, Lieberman IH, Reinhardt MK, Hussein M (2002) Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma. J Clin Oncol 20(9):2382–2387

    Article  PubMed  CAS  Google Scholar 

  18. Gangi A, Guth S, Imbert JP, Marin H, Dietemann JL (2003) Percutaneous vertebroplasty: indications, technique, and results. Radiographics 23(2):e10

    Article  PubMed  Google Scholar 

  19. Lieberman IH, Dudeney S, Reinhardt MK, Bell G (2001) Initial outcome and efficacy of “kyphoplasty” in the treatment of painful osteoporotic vertebral compression fractures. Spine (Phila Pa 1976) 26(14):1631–1638

    Article  CAS  Google Scholar 

  20. McDonald RJ, Trout AT, Gray LA, Dispenzieri A, Thielen KR, Kallmes DF (2008) Vertebroplasty in multiple myeloma: outcomes in a large patient series. AJNR Am J Neuroradiol 29(4):642–648

    Article  PubMed  CAS  Google Scholar 

  21. Kose KC, Cebesoy O, Akan B, Altinel L, Dincer D, Yazar T (2006) Functional results of vertebral augmentation techniques in pathological vertebral fractures of myelomatous patients. J Natl Med Assoc 98(10):1654–1658

    PubMed  Google Scholar 

  22. Astolfi S, Scaramuzzo L, Logroscino CA (2009) A minimally invasive surgical treatment possibility of osteolytic vertebral collapse in multiple myeloma. Eur Spine J 18(Suppl 1):115–121

    Article  PubMed  Google Scholar 

  23. Ramos L, de Las Heras JA, Sanchez S et al (2006) Medium-term results of percutaneous vertebroplasty in multiple myeloma. Eur J Haematol 77(1):7–13

    Article  PubMed  Google Scholar 

  24. Gangi A, Kastler BA, Dietemann JL (1994) Percutaneous vertebroplasty guided by a combination of CT and fluoroscopy. AJNR Am J Neuroradiol 15(1):83–86

    PubMed  CAS  Google Scholar 

  25. Aebli N, Krebs J, Davis G, Walton M, Williams MJ, Theis JC (2002) Fat embolism and acute hypotension during vertebroplasty: an experimental study in sheep. Spine 27(5):460–466

    Article  PubMed  Google Scholar 

  26. Krebs J, Ferguson SJ, Hoerstrup SP, Goss BG, Haeberli A, Aebli N (2008) Influence of bone marrow fat embolism on coagulation activation in an ovine model of vertebroplasty. J Bone Joint Surg Am 90(2):349–356

    Article  PubMed  Google Scholar 

  27. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2):149–158

    Article  PubMed  CAS  Google Scholar 

  28. Monticone M, Baiardi P, Ferrari S et al (2009) Development of the Italian version of the Oswestry disability index (ODI-I): a cross-cultural adaptation, reliability, and validity study. Spine (Phila Pa 1976) 34(19):2090–2095

    Article  Google Scholar 

  29. Vogel MN, Weisel K, Maksimovic O et al (2009) Pathologic fractures in patients with multiple myeloma undergoing bisphosphonate therapy: incidence and correlation with course of disease. AJR Am J Roentgenol 193(3):656–661

    Article  PubMed  Google Scholar 

  30. Lecouvet F, Richard F, Vande Berg B et al (1997) Long-term effects of localized spinal radiation therapy on vertebral fractures and focal lesions appearance in patients with multiple myeloma. Br J Haematol 96(4):743–745

    Article  PubMed  CAS  Google Scholar 

  31. Hiwatashi A, Westesson PL, Yoshiura T et al (2009) Kyphoplasty and vertebroplasty produce the same degree of height restoration. AJNR Am J Neuroradiol 30(4):669–673

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanni Carlo Anselmetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anselmetti, G.C., Manca, A., Montemurro, F. et al. Percutaneous Vertebroplasty in Multiple Myeloma: Prospective Long-Term Follow-Up in 106 Consecutive Patients. Cardiovasc Intervent Radiol 35, 139–145 (2012). https://doi.org/10.1007/s00270-011-0111-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-011-0111-4

Keywords

Navigation